相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study
Carlo Wilke et al.
JOURNAL OF NEUROLOGY (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
Victor L. Villemagne et al.
NATURE REVIEWS NEUROLOGY (2018)
Clinical Research on Alzheimer's Disease: Progress and Perspectives
Bin-Lu Sun et al.
NEUROSCIENCE BULLETIN (2018)
Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort The ABIDE Project
Arno de Wilde et al.
JAMA NEUROLOGY (2018)
Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes
Inge M. W. Verberk et al.
ANNALS OF NEUROLOGY (2018)
Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease
T. A. Pascoal et al.
MOLECULAR PSYCHIATRY (2017)
Comorbidity Burden of Dementia: A Hospital-Based Retrospective Study from 2003 to 2012 in Seven Cities in China
Qing-Hua Wang et al.
NEUROSCIENCE BULLETIN (2017)
Reversion From Mild Cognitive Impairment to Normal Cognition A Meta-Analysis
Michael Malek-Ahmadi
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2016)
Diagnosis and treatment of dementia in neurology outpatient departments of general hospitals in China
Jianping Jia et al.
ALZHEIMERS & DEMENTIA (2016)
MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases
Lorna Harper et al.
BRAIN (2016)
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Clifford R. Jack et al.
NEUROLOGY (2016)
Florbetapir F18 PET Amyloid Neuroimaging and Characteristics in Patients With Mild and Moderate Alzheimer Dementia
Elisabeth K. Degenhardt et al.
PSYCHOSOMATICS (2016)
Prevalence of Amyloid PET Positivity in Dementia Syndromes A Meta-analysis
Rik Ossenkoppele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
Enchi Liu et al.
NEUROLOGY (2015)
Optimal Cutoff Scores for Dementia and Mild Cognitive Impairment of the Montreal Cognitive Assessment among Elderly and Oldest-Old Chinese Population
Ji-Ping Tan et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Practical utility of amyloid and FDG-PET in an academic dementia center
Pascual Sanchez-Juan et al.
NEUROLOGY (2014)
Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
Keith A. Johnson et al.
ALZHEIMERS & DEMENTIA (2013)
Impact of molecular imaging on the diagnostic process in a memory clinic
Rik Ossenkoppele et al.
ALZHEIMERS & DEMENTIA (2013)
The relationship between single nucleotide polymorphisms of the NTRK2 gene and sporadic Alzheimer's disease in the Chinese Han population
Fan Zeng et al.
NEUROSCIENCE LETTERS (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
Thomas J. Montine et al.
ACTA NEUROPATHOLOGICA (2012)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman et al.
ALZHEIMERS & DEMENTIA (2012)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010
Thomas G. Beach et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Brain Amyloid Imaging - FDA Approval of Florbetapir F18 Injection
Lucie Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Validation of the New Interpretive Guidelines for the Clinical Dementia Rating Scale Sum of Boxes Score in the National Alzheimer's Coordinating Center Database
Sid E. O’Bryant et al.
ARCHIVES OF NEUROLOGY (2010)
Ten-year risk of dementia in subjects with mild cognitive impairment
Pieter Jelle Visser et al.
NEUROLOGY (2006)
The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
ZS Nasreddine et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Mild cognitive impairment -: beyond controversies, towards a consensus:: report of the International Working Group on Mild Cognitive Impairment
B Winblad et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: A prospective F-18-FDG-PET study
T Grimmer et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2004)
Potentially reversible conditions in 1000 consecutive memory clinic patients
A Hejl et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
分享论文
